Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6500
-0.0250 (-3.70%)
At close: Feb 4, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 41.67 million as of February 5, 2026. Its market cap has increased by 59.10% in one year.
Market Cap
41.67M
Enterprise Value
31.76M
Revenue
20.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 41.67M, a decrease of -82.30%. That is a compound annual growth rate of -32.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 41.67M | -5.90% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smoltek Nanotech Holding AB | 69.07M |
| Sound Dimension AB | 68.62M |
| Redsense Medical AB | 68.58M |
| QBNK Holding AB | 66.80M |
| Touchtech AB | 44.01M |
| Vidhance AB | 39.65M |
| AB Igrene | 37.76M |
| Lightning Group AB | 34.08M |